Gout‐associated uric acid crystals induce tophi ulcerations and impair wound healing in a novel gouty ulcer model
暂无分享,去创建一个
B. Yin | Xialin Cheng | W. Bao | Peng Wang | Yi Xue | C. Jia | Yingjun Su
[1] R. Holt,et al. OP0169 AMPUTATION PROCEDURES IN PATIENTS WITH GOUT COMPARED TO PATIENTS WITH DIABETES , 2020 .
[2] Z. Wen,et al. Etoricoxib prevents progression of osteolysis in repeated intra-articular monosodium urate-induced gouty arthritis in rats , 2020, Journal of advanced research.
[3] E. Chiu,et al. Nonhealing Ulcers in Patients with Tophaceous Gout: A Systematic Review , 2017, Advances in skin & wound care.
[4] Ju-Young Kim,et al. Ebselen Is a Potential Anti-Osteoporosis Agent by Suppressing Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Osteoclast Differentiation In vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In vivo , 2016, International journal of biological sciences.
[5] K. Sukhdeo,et al. Ulcerated tophaceous gout , 2015, BMJ Case Reports.
[6] M. Gutierrez,et al. Animal model of acute gout reproduces the inflammatory and ultrasonographic joint changes of human gout , 2015, Arthritis Research & Therapy.
[7] O. Stojadinović,et al. Clinical application of growth factors and cytokines in wound healing , 2014, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[8] M. Doherty,et al. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study , 2014, BDJ.
[9] S. Juraschek,et al. Body mass index, obesity, and prevalent gout in the United States in 1988–1994 and 2007–2010 , 2013, Arthritis care & research.
[10] D. Khanna,et al. Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey , 2012, Health and Quality of Life Outcomes.
[11] Nicola Dalbeth,et al. Mechanisms of joint damage in gout: evidence from cellular and imaging studies , 2012, Nature Reviews Rheumatology.
[12] Shin-Seok Lee,et al. Bone destruction by receptor activator of nuclear factor κB ligand-expressing T cells in chronic gouty arthritis , 2011, Arthritis research & therapy.
[13] Cord Sunderkötter,et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. , 2011, The Journal of clinical investigation.
[14] G. B. Sandim,et al. Ultrasound features of tophi in chronic tophaceous gout , 2011, Skeletal Radiology.
[15] W. Marston,et al. Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy. , 2009, Journal of vascular surgery.
[16] E. de Miguel,et al. Asymptomatic Hyperuricemia: Impact of Ultrasonography , 2008, Nucleosides, nucleotides & nucleic acids.
[17] G. Lazarus,et al. Treating the chronic wound: A practical approach to the care of nonhealing wounds and wound care dressings. , 2008, Journal of the American Academy of Dermatology.
[18] N. Kamatani,et al. Trends in the manifestations of gout in Taiwan. , 2003, Rheumatology.
[19] H. Schumacher,et al. Hydroxychloroquine inhibits matrix metalloprotease activity in experimental calcium pyrophosphate dihydrate (CPPD) crystal induced inflammation in the rat subcutaneous air pouch , 2000, InflammoPharmacology.
[20] E. Middelkoop,et al. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. , 1998, The Journal of investigative dermatology.
[21] R. Tarnuzzer,et al. Biochemical analysis of acute and chronic wound environments , 1996, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[22] G. Carrera,et al. Tophaceous gout: a clinical and radiographic assessment. , 1984, Arthritis and rheumatism.